Latest Breaking News On - Tanabe pharma corporation - Page 1 : comparemela.com

Mitsubishi Chemical : Announcement of launch of SGLT2 inhibitor "CANAGLU OD Tablets" ～Adoption of Environmentally Friendly Biomass-plastic PTP Sheets～NEW

Mitsubishi Chemical : Announcement of launch of SGLT2 inhibitor "CANAGLU OD Tablets" ～Adoption of Environmentally Friendly Biomass-plastic PTP Sheets～NEW
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Osaka
Japan
Chuo-ku
Tokyo
Akihiro-tsujimura
Mitsubishi-tanabe-pharma-corporation-head-office
Communications-division
Osaka-communications-department
Mitsubishi-chemical-group-corporation
Mitsubishi-chemical-corporation
Mitsubishi-chemical-group
Environmentally-friendly-biomass-plastic

Santen Pharmaceutical : Alesion® Eyelid Cream 0.5%, a new treatment for allergic conjunctivitis, goes on sale in Japan

Santen Pharmaceutical : Alesion® Eyelid Cream 0.5%, a new treatment for allergic conjunctivitis, goes on sale in Japan
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Japan
Osaka
Yasutaka-kuragaki
Ippei-kurihara
Tanabe-pharma
Osaka-communications-dept
National-health-insurance
Mitsubishi-chemical-group
Mitsubishi-tanabe-pharma-corporation
Boehringer-ingelheim
Head-of-japan-pharmaceutical-business-division
Santen-pharmaceutical-co-ltd

Global Health Innovative Technology Fund (GHIT Fund): Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions

Global Health Innovative Technology Fund (GHIT Fund): Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Bonn
Nordrhein-westfalen
Germany
India
Tokyo
Japan
Nagasaki
Yamagata
Switzerland
Japanese
Mina-ohata
Nancy-moss

Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions

Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Germany
Switzerland
Japan
Tokyo
Nagasaki
Yamagata
India
Bonn
Nordrhein-westfalen
Japanese
Mina-ohata
Nancy-moss

Santen Pharmaceutical : and Mitsubishi Tanabe Pharma announce the conclusion of a contract for the joint sales promotion in Japan of Alesion® Eyelid Cream 0.5%, a new treatment for allergic conjunctivitis

Santen Pharmaceutical : and Mitsubishi Tanabe Pharma announce the conclusion of a contract for the joint sales promotion in Japan of Alesion® Eyelid Cream 0.5%, a new treatment for allergic conjunctivitis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Osaka
Japan
Tanabe-pharma
National-health-insurance
Santen-pharmaceutical-co-ltd
Corporate-communications
Mitsubishi-tanabe-pharma-corporation
Osaka-communications-dept
Mitsubishi-chemical-group
Mitsubishi-tanabe-pharma
Eyelid-cream
Ophthalmic-solution